Neo Ivy Capital Management Vertex Pharmaceuticals Inc Transaction History

Neo Ivy Capital Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 24, 2023	BUY	$285.76 - $321.48 $533,228 - $599,881	1,866 New	1,866 $538,000
Q2 2022 Aug 16, 2022	BUY	$234.96 - $292.55 $46,522 - $57,924	198 Added 165.0%	318 $89,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $26,570 - $31,316	120 New	120 $32,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $160,371 - $202,445	-906 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $23,762 - $26,591	131 Added 16.9%	906 $263,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $133,680 - $157,644	713 Added 1150.0%	775 $156,000
Q1 2021 Oct 07, 2021	BUY	$207.02 - $241.31 $12,835 - $14,961	62 New	62 $13,000
Q2 2020 Aug 17, 2020	SELL	$225.48 - $295.8 $204,284 - $267,994	-906 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$225.48 - $295.8 $204,284 - $267,994	906 New	906 $263,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $612,095 - $759,289	-3,064 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $680,176 - $913,552	-4,080 Reduced 57.11%	3,064 $671,000
Q3 2019 Nov 21, 2019	BUY	$166.23 - $187.09 $1.19 Million - $1.34 Million	7,144 New	7,144 $1.29 Million
Q2 2019 Aug 15, 2019	SELL	$164.61 - $190.37 $216,955 - $250,907	-1,318 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $215,796 - $256,614	1,318 New	1,318 $242,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.